December 4, 2017
Northwest Biotherapeutics (NWBO) completed a $12 M financing
November 28, 2017
Cesca Therapeutics (KOOL) proposes 900 K share offering priced at $3.00
November 16, 2017
AxoGen (AXGN) Prices offering of 2 M share at $21.00
October 30, 2017
Pluristem (PSTI) proposes 8.87 M share offering with different pricing on Tel Aviv Stock exchange (TASE)
October 23, 2017
uniQure (QURE) proposes 5 M share offering
October 12, 2017
BioTime (NYSEMKT: BTX) proposes 9.515 M share offering
September 20, 2017
Juno Therapeutics (JUNO) proposes $225 M follow-on offering
August 31, 2017
VistaGen (VTGN) prices 1.37 M share offering at $1.75 with 1.89 M warrants attached
August 3, 2017
Spark Therapeutics (ONCE) Proposes 4.605 M share offering to raise $350 M
June 26, 2017
bluebird bio (BLUE) prices $350 M share offering at $105.00
June 20, 2017
Sangamo Therapeutics (SGMO) proposes $72.5 M offering
May 8, 2017
Capricor Therapeutics (CAPR) 1.96 M share offering priced at $3.10
April 10, 2017
Cytori (CYTX) 8.6 M share offering priced at $1.10 after stock jumps on BARDA news
April 1, 2017
Capricor Therapeutics (CAPR) at-the-market offering of $5 M
March 27, 2017
Mesoblast (MESO) $40 M offering of 26.25 M shares priced at AUS2.00
March 22, 2017
Bellicum Pharmaceuticals (BLCM) proposes 5M share offering at $12.00 per share
March 21, 2017
REGENXBIO (RGNX) proposes 3.7 M share offering priced at $20.50 for proceeds of $75 M
March 17, 2017
Northwest Bio (NWBO) yet another offering, this time of $7.5 M
March 7, 2017
Fibrocell Sciences (FCSC) proposes convertible preferred 8 M unit financing for $8 M
February 10, 2017
Biostage (BSTG) offering of 20 M common and 100% warrant coverage at $0.40
February 9, 2017
BioTime (NYSEMKT: BTX) Proposes offering of 6.48 M shares at $2.70
January 26, 2017
Athersys (ATHX) prices offering at $1.01 and is DOWN -$0.48 in the pre-market
January 19, 2017
Stemline Therapeutics (STML) proposes 4.5 M share $45 M offering, priced at $10.00
January 18, 2017
Pluristem (PSTI) upsizes share offering to 12.22 M shares with 50% warrant coverage priced at $1.225
December 15, 2016
Vericel (VCEL) proposes 6.2 M share $17 M offering at $2.75
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.